• HCV infection in liver and kidney transplant

  • HCV infection in liver and kidney transplant

  • HCV infection in liver and kidney transplant

#Infection #Middle East

Live Session:

Wednesday, June 16, 2021 - 7:00 PM (Local time in Beirut)
Local time (Corresponding time at your current location)

Join us:



Infections are a major cause of morbidity and mortality in kidney transplant recipients. Due to the prevalence of HCV infection in the general population in the Middle East, especially Egypt, sometimes transplanting patients who are HCV positive or from donors who are positive is unavoidable.

The introduction of anti-HCV medication and pre-transplant screening, immunization, and post-transplant prophylactic antimicrobials has helped reduce that risk. However, because transplant recipients may not manifest typical signs and symptoms of infection, diagnoses may be confounded.

Furthermore, treatment regimens may be complicated by drug interactions and the need to maintain immunosuppression to avoid allograft rejection. Transplantation of a kidney from a hepatitis C virus (HCV)-infected kidney donor may cause HCV infection in the recipient.

HCV treatment in liver transplant

Mohamed Hani Hafez

Emeritus Professor of Medicine and Nephrology
Cairo University
Cairo, Egypt

  • Emeritus Professor of Medicine and Nephrology-Cairo University Egypt
  • President of Egyptian Society of Nephrology and Transplantation (ESNT) since Feb 2018
  • Vice-President of Egyptian Society of Organ Transplantation (ESOT)since 2017
  • Chief of nephrology councils of Egyptian and Arab boards
  • Member of Steering Committee of Supreme Council of Egyptian Universities and Egyptian National Board
  • Secretary-General of Middle East Society of Organ Transplantation (MESOT)
  • Acting Secretary & Treasurer of AFEAN( African Society of Nephrology)


HCV infection in kidney transplant

Niraj Manubhai Desai

Surgical Director, Kidney and Pancreas Transplant Assistant Professor of Surgery The Johns Hopkins Hospital Baltimore, USA
A transplant surgeon specializing in abdominal transplantation, Dr. Desai previously worked at Washington University in St. Louis, MO. His special interests include kidney transplantation in adults and children, as well as pancreas and pancreatic islet transplantation.


Adib Rizvi

Professor and Director
Sindh Institute of Urology and Transplantation (SIUT)
Karachi, Pakistan

Anwar Naqvi

Professor of Urology
Sindh Institute of Urology and Transplantation (SIUT)
Karachi, Pakistan

Schedule (90 min):

  • 05 min

    Welcome and introduction by the Chair
  • 25 min

    Presentation: HCV infection in kidney transplant, Niraj Manubhai Desai, USA

  • 05 min

    Live Q&A with Niraj Manubhai Desai, USA

  • 25 min

    Presentation: HCV treatment in liver transplant, Mohamed Hani Hafez, Egypt

  • 05 min

    Live Q&A with Mohamed Hani Hafez, Egypt

  • 20 min

    Interactive panel discussion with audience participation led by the Chair
  • 05 min

    Masterclass closig remarks

Join Our Mailing List

Ask a Question

Masterclass Prospectus Request